Bee venom: Yesterday's enemy becomes modern medicine for skin cancer

Amr Ahmed El-Arabey1, Hamed A Ghramh2

  • 1Applied College, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Center of Bee Research and its Products, King Khalid University, P.O. Box 9004, Abha, 61413, Saudi Arabia; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo, 11751, Egypt.

PubMed

Insights

Bee venom shows potential in treating malignant melanoma, a lethal skin cancer. Further research is needed to explore its clinical impact and overcome challenges in developing this novel therapy.

Area of Science:

  • Oncology
  • Dermatology
  • Toxicology

Background:

  • Malignant melanoma is a deadly skin cancer with limited treatment options, especially in advanced stages.
  • Current therapies like chemotherapy and immunotherapy often fail due to complex cancer mechanisms.
  • There is a critical need for innovative treatments to combat rising melanoma incidence.

Purpose of the Study:

  • To comprehensively review the clinical impact of bee venom on skin cancer.
  • To explore bee venom as a potential alternative therapy for malignant melanoma.
  • To identify challenges and future directions for bee venom in cancer treatment.

Main Methods:

  • Literature review of existing research on bee venom and cancer.
  • Analysis of studies investigating bee venom's effects on melanoma cells and models.
  • Assessment of clinical data, where available, on bee venom therapy for skin cancer.

Main Results:

  • Preliminary research suggests bee venom possesses anti-cancer properties affecting various malignancies.
  • Specific studies indicate bee venom components may inhibit melanoma growth and metastasis.
  • However, clinical evidence and research specifically on bee venom for skin cancer remain limited.

Conclusions:

  • Bee venom presents a promising, yet under-explored, therapeutic avenue for malignant melanoma.
  • Further rigorous research is essential to validate its efficacy and safety for skin cancer treatment.
  • Addressing current research gaps will pave the way for novel bee venom-based therapies.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K